Tags

Type your tag names separated by a space and hit enter

Membranous dysmenorrhea: the forgotten entity.

Abstract

BACKGROUND

Membranous dysmenorrhea involves the spontaneous slough of the endometrium in one cylindrical or membranous piece that retains the shape of the uterine cavity. Because this entity is rarely mentioned in the medical literature, the purpose of this report is to describe two such cases.

CASES

An 18-year-old nullipara with regular menstrual cycles presented with membranous dysmenorrhea after taking the contraceptive Gynera (Gestodene 0.075 mg, ethinyl estradiol 0.030 mg). Symptoms disappeared when the medication was discontinued. The second patient, a 26-year-old woman, gravida 1, para 1, was on a 10-day monthly regimen of Provera (medroxyprogesterone acetate) 2.5 mg/day for dysfunctional uterine bleeding. When the Provera dose was increased to 10 mg/day, the symptoms disappeared.

CONCLUSION

Membranous dysmenorrhea is "a disease of theories" with various recommended medications. When this condition is caused by iatrogenic treatment, the best approach is to discontinue the offending drug or change its dosage.

Links

  • Aggregator Full Text
  • Authors+Show Affiliations

    ,

    Department of Obstetrics and Gynecology, Beilinson Medical Center, Petah Tiqva, Israel.

    , , ,

    Source

    Obstetrics and gynecology 85:5 Pt 2 1995 May pg 891-2

    MeSH

    Adolescent
    Adult
    Contraceptives, Oral
    Decidua
    Dose-Response Relationship, Drug
    Dysmenorrhea
    Endometrium
    Female
    Humans
    Medroxyprogesterone Acetate
    Membranes
    Menstruation Disturbances
    Norpregnenes
    Pregnancy
    Vaginal Diseases

    Pub Type(s)

    Case Reports
    Journal Article

    Language

    eng

    PubMed ID

    7724151

    Citation

    Rabinerson, D, et al. "Membranous Dysmenorrhea: the Forgotten Entity." Obstetrics and Gynecology, vol. 85, no. 5 Pt 2, 1995, pp. 891-2.
    Rabinerson D, Kaplan B, Fisch B, et al. Membranous dysmenorrhea: the forgotten entity. Obstet Gynecol. 1995;85(5 Pt 2):891-2.
    Rabinerson, D., Kaplan, B., Fisch, B., Braslavski, D., & Neri, A. (1995). Membranous dysmenorrhea: the forgotten entity. Obstetrics and Gynecology, 85(5 Pt 2), pp. 891-2.
    Rabinerson D, et al. Membranous Dysmenorrhea: the Forgotten Entity. Obstet Gynecol. 1995;85(5 Pt 2):891-2. PubMed PMID: 7724151.
    * Article titles in AMA citation format should be in sentence-case
    TY - JOUR T1 - Membranous dysmenorrhea: the forgotten entity. AU - Rabinerson,D, AU - Kaplan,B, AU - Fisch,B, AU - Braslavski,D, AU - Neri,A, PY - 1995/5/1/pubmed PY - 1995/5/1/medline PY - 1995/5/1/entrez SP - 891 EP - 2 JF - Obstetrics and gynecology JO - Obstet Gynecol VL - 85 IS - 5 Pt 2 N2 - BACKGROUND: Membranous dysmenorrhea involves the spontaneous slough of the endometrium in one cylindrical or membranous piece that retains the shape of the uterine cavity. Because this entity is rarely mentioned in the medical literature, the purpose of this report is to describe two such cases. CASES: An 18-year-old nullipara with regular menstrual cycles presented with membranous dysmenorrhea after taking the contraceptive Gynera (Gestodene 0.075 mg, ethinyl estradiol 0.030 mg). Symptoms disappeared when the medication was discontinued. The second patient, a 26-year-old woman, gravida 1, para 1, was on a 10-day monthly regimen of Provera (medroxyprogesterone acetate) 2.5 mg/day for dysfunctional uterine bleeding. When the Provera dose was increased to 10 mg/day, the symptoms disappeared. CONCLUSION: Membranous dysmenorrhea is "a disease of theories" with various recommended medications. When this condition is caused by iatrogenic treatment, the best approach is to discontinue the offending drug or change its dosage. SN - 0029-7844 UR - https://www.unboundmedicine.com/medline/citation/7724151/Membranous_dysmenorrhea:_the_forgotten_entity_ L2 - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=linkout&SEARCH=7724151.ui DB - PRIME DP - Unbound Medicine ER -